Serum soluble triggering receptor expressed on myeloid cells‐2 was not altered by rTMS in patients with treatment‐resistant depression

AIM: Repetitive transcranial magnetic stimulation (rTMS) is one of the most effective and minimally invasive treatments for treatment‐resistant depression (TRD). However, the mechanism underlying the therapeutic effects of rTMS in patients with TRD remains unclear. In recent years, the pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tateishi, Hiroshi, Matsushima, Jun, Kunitake, Hiroko, Imamura, Yoshiomi, Kunitake, Yutaka, Murakawa, Toru, Mawatari, Seiji, Kojima, Ryohei, Fujii, Yuka, Kikuchi, Jun, Fukuchi, Junko, Sakemura, Yuta, Shiraishi, Takumi, Nagahama, Chika, Maekawa, Toshihiko, Asami, Toyoko, Mizoguchi, Yoshito, Monji, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275288/
https://www.ncbi.nlm.nih.gov/pubmed/36907597
http://dx.doi.org/10.1002/npr2.12332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275288/
https://www.ncbi.nlm.nih.gov/pubmed/36907597
http://dx.doi.org/10.1002/npr2.12332

Ejemplares similares